SCHEMBL20151844

SCHEMBL20151844

CCOC(=O)OC(C)OC(=O)CCCN(Cc1ccccc1)c1cc(C)ccc1C=O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.37
KMT2A Q03164 5/20 0.35
ATM Q13315 3/20 0.35
MEN1 O00255 3/20 0.35
ALDH1A1 P00352 4/20 0.35
POLB P06746 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
LTA4H P09960 4/20 0.35
MAPK1 P28482 3/20 0.35
MAPT P10636 2/20 0.35
PPARD Q03181 4/20 0.34
PPARA Q07869 3/20 0.34
TDP1 Q9NUW8 1/20 0.33
PPARG P37231 2/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151848 0.91 KMT2A (0.36) ALOX5KMT2AATMMEN1ALDH1A1
SCHEMBL20137060 0.89 MGLL (0.41) ALOX5ALDH1A1POLBL3MBTL1LMNA
SCHEMBL20151843 0.80 PPARD (0.42) KMT2AATMALDH1A1POLBMAPK1
SCHEMBL20151842 0.80 PPARD (0.36) ALOX5KMT2AATMMEN1ALDH1A1
SCHEMBL20137125 0.79 MGLL (0.39) ALDH1A1POLBL3MBTL1MAPTPPARD
SCHEMBL20151846 0.79 PPARD (0.38) ALOX5KMT2AATMMEN1ALDH1A1
SCHEMBL20151838 0.78 PPARG (0.39) KMT2AMEN1ALDH1A1L3MBTL1LMNA
SCHEMBL20179985 0.76 PPARG (0.38) ALDH1A1POLBL3MBTL1MAPTPPARD
SCHEMBL20157947 0.76 PPARG (0.36) ALDH1A1POLBL3MBTL1LMNAHSD17B10
SCHEMBL20166820 0.76 ALOX5 (0.40) ALOX5KMT2AALDH1A1LTA4HMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134674-A1 MAGL INHIBITORS H. LUNDBECK A/S (DK) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134674-A1 MAGL INHIBITORS MAG, MAGI3, MGLL ALOX5 1065/4885KMT2A 2263/4885ATM 4676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.